VistaGen Therapeutics, Inc.
VTGNHealthcare|Biotechnology|US
$0.16
-0.00 (-0.85%)
DCF Value
$0.69
Tangible Book / Share
$0.57
Cash / Share
$0.74
Ownership Breakdown
79.0%
Float
44.4M
Shares Outstanding
35.1M
Float Shares
Major Holders (37)
Combined: 186.5%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Janus Henderson Biotech Innovation Master Fund Ltd | Investment company | 11.70% | 3,575,276 | Sep 8, 2025 | 13D/G |
| Lampert Mark N | Individual | 9.97% | 3,084,324 | Feb 14, 2025 | 13D/G |
| BVF Inc/Il | Corporation | 9.97% | 3,084,324 | Feb 14, 2025 | 13D/G |
| BVF Partners L P/Il | IA, PN | 9.97% | 3,084,324 | Feb 14, 2025 | 13D/G |
| Commodore Capital LP | IA, PN | 9.90% | 4,244,590 | Aug 14, 2026 | 13D/G |
| Commodore Capital Master LP | Partnership | 9.90% | 4,244,590 | Aug 14, 2026 | 13D/G |
| Michael Kramarz | HC, IN | 9.90% | 4,244,590 | Aug 14, 2026 | 13D/G |
| Robert Egen Atkinson | HC, IN | 9.90% | 4,244,590 | Aug 14, 2026 | 13D/G |
| BVF GP Holdings LLC | Other | 9.40% | 2,879,229 | Feb 14, 2025 | 13D/G |
| Chen Yu | Individual | 6.70% | 2,960,404 | Aug 14, 2026 | 13D/G |
| Biotechnology Value Fund L P | Partnership | 5.40% | 1,589,495 | Feb 14, 2025 | 13D/G |
| BVF I GP LLC | Other | 5.40% | 1,589,495 | Feb 14, 2025 | 13D/G |
| TCG Crossover GP II, LLC | Other | 5.10% | 2,220,303 | Aug 14, 2026 | 13D/G |
| TCG Crossover Fund II, L.P. | Partnership | 5.10% | 2,220,303 | Aug 14, 2026 | 13D/G |
| Great Point Partners, LLC | IA, OO | 4.95% | 2,055,834 | Feb 17, 2026 | 13D/G |
| Dr. Jeffrey R. Jay, M.D. | HC, IN | 4.95% | 2,055,834 | Feb 17, 2026 | 13D/G |
| Ms. Lillian Nordahl | HC, IN | 4.95% | 2,055,834 | Feb 17, 2026 | 13D/G |
| Daniel Mack | Holding company | 4.71% | 1,953,045 | Feb 13, 2026 | 13D/G |
| Nantahala Capital Management, LLC | Investment adviser | 4.71% | 1,953,045 | Feb 13, 2026 | 13D/G |
| Wilmot B. Harkey | Holding company | 4.71% | 1,953,045 | Feb 13, 2026 | 13D/G |
| The Vanguard Group | Investment adviser | 4.62% | 1,824,738 | Jan 30, 2026 | 13D/G |
| Biotechnology Value Fund II LP | Partnership | 4.40% | 1,289,734 | Feb 14, 2025 | 13D/G |
| BVF II GP LLC | Other | 4.40% | 1,289,734 | Feb 14, 2025 | 13D/G |
| Kenneth Griffin | HC, IN | 4.20% | 1,158,219 | Nov 14, 2024 | 13D/G |
| Citadel GP LLC | HC, OO | 4.00% | 1,119,794 | Nov 14, 2024 | 13D/G |
| Citadel Advisors Holdings LP | HC, PN | 4.00% | 1,119,794 | Nov 14, 2024 | 13D/G |
| Citadel Advisors LLC | IA, HC, OO | 4.00% | 1,119,794 | Nov 14, 2024 | 13D/G |
| TCG Crossover GP I, LLC | Other | 1.80% | 740,101 | Aug 14, 2026 | 13D/G |
| TCG Crossover Fund I, L.P. | Partnership | 1.80% | 740,101 | Aug 14, 2026 | 13D/G |
| StemPoint Capital LP | Investment adviser | 1.50% | 616,749 | Feb 17, 2026 | 13D/G |
| StemPoint Capital Management GP LLC | Other | 1.50% | 616,749 | Feb 17, 2026 | 13D/G |
| Michelle Ross | HC, IN | 1.50% | 616,749 | Feb 17, 2026 | 13D/G |
| BVF Partners OS Ltd. | Corporation | 0.60% | 158,606 | Feb 14, 2025 | 13D/G |
| Biotechnology Value Trading Fund OS LP | Partnership | 0.60% | 158,606 | Feb 14, 2025 | 13D/G |
| Citadel Securities GP LLC | HC, OO | 0.10% | 38,425 | Nov 14, 2024 | 13D/G |
| Citadel Securities Group LP | HC, PN | 0.10% | 38,425 | Nov 14, 2024 | 13D/G |
| Citadel Securities LLC | BD, OO | 0.10% | 38,425 | Nov 14, 2024 | 13D/G |
Insider Trades (100)
Last 4 quarters: 928,760 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Williamson Douglas J | director | Jul 29, 2026 | AWARD | 40,826 | $0.24 | $9.9K | Form 4 |
| Williamson Douglas J | Jul 29, 2026 | OTHER | 0 | — | — | Form 4 | |
| Adler Reid G. | Chief Legal Officer | Jun 30, 2026 | AWARD | 36,818 | $0.19 | $7.1K | Form 4 |
| Tressler Nick B. | Chief Financial Officer | Jun 30, 2026 | AWARD | 11,712 | $0.19 | $2.2K | Form 4 |
| Singh Shawn | director, officer: President and CEO | Jun 30, 2026 | AWARD | 36,818 | $0.19 | $7.1K | Form 4 |
| Angelov Angel S | Chief Medical Officer | May 18, 2026 | AWARD | 150,000 | $0.60 | $89.3K | Form 4 |
| Angelov Angel S | May 18, 2026 | OTHER | 0 | — | — | Form 4 | |
| Tressler Nick B. | Chief Financial Officer | Apr 7, 2026 | AWARD | 75,000 | $0.54 | $40.2K | Form 4 |
| Singh Shawn | director, officer: President and CEO | Apr 7, 2026 | AWARD | 71,268 | $0.54 | $38.2K | Form 4 |
| Singh Shawn | director, officer: President and CEO | Apr 7, 2026 | AWARD | 3,732 | $0.54 | $2.0K | Form 4 |
| Prince Joshua S. | Chief Operating Officer | Apr 7, 2026 | AWARD | 56,248 | $0.54 | $30.1K | Form 4 |
| Prince Joshua S. | Chief Operating Officer | Apr 7, 2026 | AWARD | 18,752 | $0.54 | $10.0K | Form 4 |
| Cote Elissa S. | Chief Corp Development Officer | Apr 7, 2026 | AWARD | 75,000 | $0.54 | $40.2K | Form 4 |
| Adler Reid G. | Chief Legal Officer | Apr 7, 2026 | AWARD | 56,247 | $0.54 | $30.1K | Form 4 |
| Adler Reid G. | Chief Legal Officer | Apr 7, 2026 | AWARD | 18,753 | $0.54 | $10.0K | Form 4 |
| Prince Joshua S. | Chief Operating Officer | Dec 31, 2025 | AWARD | 4,386 | $0.56 | $2.5K | Form 4 |
| Tressler Nick B. | Chief Financial Officer | Dec 1, 2025 | AWARD | 150,000 | $4.43 | $664.5K | Form 4 |
| Tressler Nick B. | Dec 1, 2025 | OTHER | 0 | — | — | Form 4 | |
| Edick Paul R | director | Oct 27, 2025 | AWARD | 35,200 | $3.90 | $137.3K | Form 4 |
| Edick Paul R | Oct 27, 2025 | OTHER | 0 | — | — | Form 4 | |
| SAXE JON S | director | Sep 9, 2025 | AWARD | 17,600 | $3.61 | $63.5K | Form 4 |
| Rotunno Mary L. | director | Sep 9, 2025 | AWARD | 17,600 | $3.61 | $63.5K | Form 4 |
| FitzPatrick Margaret M | director | Sep 9, 2025 | AWARD | 17,600 | $3.61 | $63.5K | Form 4 |
| Curley Joanne | director | Sep 9, 2025 | AWARD | 17,600 | $3.61 | $63.5K | Form 4 |
| Cunningham Ann Michelle | director | Sep 9, 2025 | AWARD | 17,600 | $3.61 | $63.5K | Form 4 |
| Prince Joshua S. | Chief Operating Officer | Jun 30, 2025 | AWARD | 4,882 | $1.70 | $8.3K | Form 4 |
| Adler Reid G. | Chief Legal Officer | Jun 30, 2025 | AWARD | 7,541 | $1.70 | $12.8K | Form 4 |
| Anderson Cynthia Lynn | CHIEF FINANCIAL OFFICER | Jun 30, 2025 | AWARD | 6,617 | $1.70 | $11.2K | Form 4 |
| Singh Shawn | director, officer: President and CEO | Jun 30, 2025 | AWARD | 7,541 | $1.70 | $12.8K | Form 4 |
| Cote Elissa S. | Chief Corp Development Officer | Jun 23, 2025 | AWARD | 150,000 | $1.96 | $294.0K | Form 4 |
| Cote Elissa S. | Jun 23, 2025 | OTHER | 0 | — | — | Form 4 | |
| Anderson Cynthia Lynn | CHIEF FINANCIAL OFFICER | Jun 23, 2025 | AWARD | 100,000 | $1.96 | $196.0K | Form 4 |
| Prince Joshua S. | Chief Operating Officer | Jun 23, 2025 | AWARD | 100,000 | $1.96 | $196.0K | Form 4 |
| Adler Reid G. | Chief Legal Officer | Jun 23, 2025 | AWARD | 100,000 | $1.96 | $196.0K | Form 4 |
| Singh Shawn | director, officer: President and CEO | Jun 23, 2025 | AWARD | 300,000 | $1.96 | $588.0K | Form 4 |
| Prince Joshua S. | Chief Operating Officer | Dec 31, 2024 | AWARD | 3,310 | $2.51 | $8.3K | Form 4 |
| Anderson Cynthia Lynn | CHIEF FINANCIAL OFFICER | Dec 31, 2024 | AWARD | 2,592 | $2.51 | $6.5K | Form 4 |
| SAXE JON S | director | Sep 6, 2024 | AWARD | 14,100 | $3.25 | $45.8K | Form 4 |
| GIN JERRY B | director | Sep 6, 2024 | AWARD | 14,100 | $3.25 | $45.8K | Form 4 |
| Curley Joanne | director | Sep 6, 2024 | AWARD | 14,100 | $3.25 | $45.8K | Form 4 |
| Cunningham Ann Michelle | director | Sep 6, 2024 | AWARD | 14,100 | $3.25 | $45.8K | Form 4 |
| Rotunno Mary L. | director | Sep 6, 2024 | AWARD | 14,100 | $3.25 | $45.8K | Form 4 |
| FitzPatrick Margaret M | director | Sep 6, 2024 | AWARD | 14,100 | $3.25 | $45.8K | Form 4 |
| Prince Joshua S. | Chief Operating Officer | Jun 28, 2024 | AWARD | 2,671 | $2.96 | $7.9K | Form 4 |
| Anderson Cynthia Lynn | CHIEF FINANCIAL OFFICER | Jun 28, 2024 | AWARD | 3,592 | $2.96 | $10.6K | Form 4 |
| Adler Reid G. | CHF CORP DEVEL OFF, GEN COUNS | Jun 28, 2024 | AWARD | 4,854 | $2.96 | $14.4K | Form 4 |
| Singh Shawn | director, officer: CHIEF EXECUTIVE OFFICER | Jun 28, 2024 | AWARD | 4,854 | $2.96 | $14.4K | Form 4 |
| Singh Shawn | director, officer: CHIEF EXECUTIVE OFFICER | Jun 24, 2024 | AWARD | 500,000 | $3.23 | $1.6M | Form 4 |
| Adler Reid G. | CHF CORP DEVEL OFF, GEN COUNS | Jun 24, 2024 | AWARD | 170,000 | $3.23 | $549.1K | Form 4 |
| Anderson Cynthia Lynn | CHIEF FINANCIAL OFFICER | Jun 24, 2024 | AWARD | 150,000 | $3.23 | $484.5K | Form 4 |
| Prince Joshua S. | Chief Operating Officer | Jun 24, 2024 | AWARD | 150,000 | $3.23 | $484.5K | Form 4 |
| Rotunno Mary L. | director | Mar 4, 2024 | AWARD | 12,500 | $4.85 | $60.6K | Form 4 |
| GIN JERRY B | director | Mar 4, 2024 | AWARD | 12,500 | $4.85 | $60.6K | Form 4 |
| FitzPatrick Margaret M | director | Mar 4, 2024 | AWARD | 12,500 | $4.85 | $60.6K | Form 4 |
| Curley Joanne | director | Mar 4, 2024 | AWARD | 12,500 | $4.85 | $60.6K | Form 4 |
| Cunningham Ann Michelle | director | Mar 4, 2024 | AWARD | 12,500 | $4.85 | $60.6K | Form 4 |
| SAXE JON S | director | Mar 4, 2024 | AWARD | 12,500 | $4.85 | $60.6K | Form 4 |
| Adler Reid G. | CHF CORP DEVEL OFF, GEN COUNS | Dec 29, 2023 | AWARD | 167 | $1.72 | $286.74 | Form 4 |
| Singh Shawn | director, officer: CHIEF EXECUTIVE OFFICER | Dec 29, 2023 | AWARD | 167 | $1.72 | $286.74 | Form 4 |
| Prince Joshua S. | Chief Operating Officer | Oct 24, 2023 | DISPOSED | 5,001 | $4.44 | $22.2K | Form 4 |
| Prince Joshua S. | Chief Operating Officer | Oct 24, 2023 | DISPOSED | 5,000 | $64.50 | $322.5K | Form 4 |
| Prince Joshua S. | Chief Operating Officer | Oct 24, 2023 | DISPOSED | 3,334 | $41.10 | $137.0K | Form 4 |
| COMMODORE CAPITAL LP | 10 percent owner | Oct 4, 2023 | AWARD | 2,788,620 | $0.00 | $2.8K | Form 4 |
| COMMODORE CAPITAL LP | 10 percent owner | Oct 4, 2023 | AWARD | 1,690,014 | $8.88 | $15.0M | Form 4 |
| COMMODORE CAPITAL LP | 10 percent owner | Oct 4, 2023 | AWARD | 1,394,310 | $5.38 | $7.5M | Form 4 |
| Anderson Cynthia Lynn | CHIEF FINANCIAL OFFICER | Aug 21, 2023 | AWARD | 8,333 | $5.34 | $44.5K | Form 4 |
| Anderson Cynthia Lynn | Aug 21, 2023 | OTHER | 0 | — | — | Form 4 | |
| COMMODORE CAPITAL LP | 10 percent owner | Aug 7, 2023 | BUY | 775,756 | $23.15 | $18.0M | Form 4 |
| COMMODORE CAPITAL LP | 10 percent owner | Aug 7, 2023 | OTHER | 0 | — | — | Form 4 |
| Singh Shawn | director, officer: CHIEF EXECUTIVE OFFICER | Jun 30, 2023 | AWARD | 167 | $1.59 | $265.45 | Form 4 |
| Adler Reid G. | CHIEF LEGAL OFFICER | Jun 30, 2023 | AWARD | 167 | $1.59 | $265.45 | Form 4 |
| DOTSON JERROLD DUANE | VP, CFO | Jun 30, 2023 | AWARD | 167 | $1.59 | $265.45 | Form 4 |
| DOTSON JERROLD DUANE | director: VP, CFO AND SECRETARY | Dec 30, 2022 | AWARD | 5,000 | $0.09 | $438.00 | Form 4 |
| Singh Shawn | director: CHIEF EXECUTIVE OFFICER | Dec 30, 2022 | AWARD | 5,000 | $0.09 | $438.00 | Form 4 |
| GIN JERRY B | director: | Aug 18, 2022 | BUY | 100,000 | $0.18 | $17.9K | Form 4 |
| Adler Reid G. | director: CHIEF LEGAL OFFICER | Aug 17, 2022 | BUY | 300,000 | $0.17 | $50.9K | Form 4 |
| Singh Shawn | director: CHIEF EXECUTIVE OFFICER | Aug 17, 2022 | BUY | 600,000 | $0.17 | $103.2K | Form 4 |
| DOTSON JERROLD DUANE | director: VP, CFO AND SECRETARY | Jun 30, 2022 | AWARD | 5,000 | $0.75 | $3.7K | Form 4 |
| Singh Shawn | director: CHIEF EXECUTIVE OFFICER | Jun 30, 2022 | AWARD | 5,000 | $0.75 | $3.7K | Form 4 |
| Smith Mark Alan | director: CHIEF MEDICAL OFFICER | Jun 30, 2022 | AWARD | 5,000 | $0.75 | $3.7K | Form 4 |
| Shah Nimish P | director: | Jul 12, 2022 | SELL | 60,000 | $0.89 | $53.4K | Form 4 |
| Venrock Healthcare Capital Partners II, L.P. | 10 percent owner | Jul 12, 2022 | SELL | 60,000 | $0.89 | $53.4K | Form 4 |
| Venrock Healthcare Capital Partners II, L.P. | 10 percent owner | Apr 6, 2022 | OTHER | 0 | — | — | Form 4 |
| Singh Shawn | director: CHIEF EXECUTIVE OFFICER | May 12, 2022 | OPTION EX. | 100,000 | $1.00 | $100.0K | Form 4 |
| Singh Shawn | director, officer: CHIEF EXECUTIVE OFFICER | May 12, 2022 | OPTION EX. | 100,000 | $1.00 | $100.0K | Form 4 |
| Adler Reid G. | director: CHIEF LEGAL OFFICER | May 2, 2022 | AWARD | 200,000 | — | — | Form 4 |
| Adler Reid G. | CHIEF LEGAL OFFICER | May 2, 2022 | DISPOSED | 0 | — | — | Form 4 |
| Adler Reid G. | CHIEF LEGAL OFFICER | May 2, 2022 | DISPOSED | 50,000 | $2.74 | $137.0K | Form 4 |
| Adler Reid G. | CHIEF LEGAL OFFICER | May 2, 2022 | DISPOSED | 25,000 | $1.41 | $35.3K | Form 4 |
| Adler Reid G. | CHIEF LEGAL OFFICER | May 2, 2022 | DISPOSED | 25,000 | $1.16 | $29.0K | Form 4 |
| Adler Reid G. | CHIEF LEGAL OFFICER | May 2, 2022 | DISPOSED | 25,000 | $0.40 | $9.9K | Form 4 |
| Adler Reid G. | CHIEF LEGAL OFFICER | May 2, 2022 | DISPOSED | 50,000 | $1.56 | $78.0K | Form 4 |
| Adler Reid G. | CHIEF LEGAL OFFICER | May 2, 2022 | DISPOSED | 50,000 | $1.37 | $68.5K | Form 4 |
| Adler Reid G. | CHIEF LEGAL OFFICER | May 2, 2022 | DISPOSED | 2,500 | $8.00 | $20.0K | Form 4 |
| Adler Reid G. | CHIEF LEGAL OFFICER | May 2, 2022 | DISPOSED | 20,000 | $1.00 | $20.0K | Form 4 |
| DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | Mar 1, 2022 | AWARD | 150,000 | $1.37 | $205.5K | Form 4 |
| Smith Mark Alan | CHIEF MEDICAL OFFICER | Mar 1, 2022 | AWARD | 150,000 | $1.37 | $205.5K | Form 4 |
| Smith Mark Alan | director: CHIEF MEDICAL OFFICER | Mar 1, 2022 | AWARD | 150,000 | — | — | Form 4 |
| Cunningham Ann Michelle | director, officer: CHIEF COMMERCIAL OFFICER | Mar 1, 2022 | AWARD | 150,000 | $1.37 | $205.5K | Form 4 |
| Cunningham Ann Michelle | director: CHIEF COMMERCIAL OFFICER | Mar 1, 2022 | AWARD | 150,000 | — | — | Form 4 |